Current recommendations for revascularization of non-infarct-related artery in patients presenting with ST-segment elevation myocardial infarction and multivessel disease

被引:2
|
作者
Towashiraporn, Korakoth [1 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Her Majesty Cardiac Ctr, Bangkok, Thailand
来源
关键词
ST-segment elevation myocardial infarction; multivessel disease; complete revascularization; percutaneous coronary intervention; infarct-related artery; PERCUTANEOUS CORONARY INTERVENTION; LESION-ONLY REVASCULARIZATION; CARDIOGENIC-SHOCK; SCIENTIFIC STATEMENT; RANDOMIZED-TRIAL; CULPRIT LESION; MANAGEMENT; PLAQUE; STEMI; OUTCOMES;
D O I
10.3389/fcvm.2022.969060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Immediate reperfusion therapy of the infarct-related artery (IRA) is the mainstay of treatment, either via primary percutaneous coronary intervention (PPCI) or thrombolytic therapy when PPCI is not feasible. Several studies have reported the incidence of multivessel disease (MVD) to be about 50% of total STEMI cases. This means that after successful PPCI of the IRA, residual lesion(s) of the non-IRA may persist. Unlike the atherosclerotic plaque of stable coronary artery disease, the residual obstructive lesion of the non-IRA contains a significantly higher prevalence of vulnerable plaques. Since these lesions are a strong predictor of acute coronary syndrome, if left untreated they are a possible cause of future adverse cardiovascular events. Percutaneous coronary intervention (PCI) of the obstructive lesion of the non-IRA to achieve complete revascularization (CR) is therefore preferable. Several major randomized controlled trials (RCTs) and meta-analyses demonstrated the clinical benefits of the CR strategy in the setting of STEMI with MVD, not only for enhancing survival but also for reducing unplanned revascularization. The CR strategy is now supported by recently published clinical practice guidelines. Nevertheless, the benefit of revascularization must be weighed against the risks from additional procedures.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Long-Term Clinical Impact of Complete Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
    Kim, Min Chul
    Jeong, Myung-Ho
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Youngkeun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (16) : S5 - S6
  • [32] EFFECTS OF REVASCULARIZATION STRATEGIES IN ELDERLY PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Patel, Gaurav
    Malik, Qasim
    Pancholy, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1223 - 1223
  • [33] Patency of infarct-related artery and platelet reactivity in patients with ST-segment elevation myocardial infarction
    Malek, Lukasz A.
    Klopotowski, Mariusz
    Spiewak, Mateusz
    Was, Joanna
    Kunicki, Pawel K.
    Ruzyllo, Witold
    Witkowski, Adam
    COR ET VASA, 2013, 55 (02) : E126 - E130
  • [34] Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
    Banning, Amerjeet S.
    Gershlick, Anthony H.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (09)
  • [35] Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
    Amerjeet S. Banning
    Anthony H. Gershlick
    Current Cardiology Reports, 2015, 17
  • [36] Elective stenting of non-infarct-related coronary arteries early after primary angioplasty in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease: In-hospital outcomes and medium-term follow up
    Rigattieri, Stefano
    Silvestri, Pasquale
    Di Russo, Cristian
    Musto, Carmine
    Ferraiuolo, Giuseppe
    Palamara, Antonio
    Loschiavo, Paolo
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 69M - 69M
  • [37] Quantitative assessment of microcirculatory resistance in infarct-related and non-infarct-related coronary arteries in patients with ST-segment elevation myocardial infarction tretaed with primary PCI
    Orlic, D.
    Ostojic, M.
    Beleslin, B.
    Tesic, M.
    Sobic-Saranovic, D.
    Stojkovic, S.
    Vukcevic, V.
    Stepanovic, J.
    Nedeljkovic, M.
    Stankovic, G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 235 - 235
  • [38] Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease
    Hirji, Sameer A.
    Stevens, Susanna R.
    Shaw, Linda K.
    Campbell, Erin C.
    Granger, Christopher B.
    Patel, Manesh R.
    Sketch, Michael H., Jr.
    Wang, Tracy Y.
    Ohman, E. Magnus
    Peterson, Eric D.
    Brennan, J. Matthew
    AMERICAN HEART JOURNAL, 2017, 194 : 116 - 124
  • [39] Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction
    Lobo, Angie S.
    Cantu, Stephanie M.
    Sharkey, Scott W.
    Grey, Elizabeth Z.
    Storey, Katelyn
    Witt, Dawn
    Benson, Gretchen
    Garberich, Ross F.
    Kubota, Yasuhiko
    Merz, C. Noel Bairey
    Henry, Timothy D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (10) : 1290 - 1300
  • [40] Impact of Multivessel Coronary Artery Disease on Long Term Prognosis in Patients with ST-segment Elevation Myocardial Infarction
    Savic, Lidija
    Mrdovic, Igor
    Asanin, Milika
    Stankovic, Sanja
    Krljanac, Gordana
    Lasica, Ratko
    JOURNAL OF CARDIOVASCULAR EMERGENCIES, 2019, 5 (02): : 66 - 71